Growth Metrics

Oruka Therapeutics (ORKA) Assets Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 33.77%
Dec 31, 2025 23.38%
Sep 30, 2025 22.98%
Jun 30, 2025 956.07%
Mar 31, 2025 927.39%
Dec 31, 2024 945.98%
Sep 30, 2024 956.78%
Jun 30, 2024 -17.62%
Mar 31, 2024 -12.73%
Dec 31, 2023 -12.12%
Sep 30, 2023 -12.86%
Jun 30, 2023 -14.59%
Mar 31, 2023 -17.55%
Dec 31, 2022 -21.56%
Sep 30, 2022 -25.30%
Jun 30, 2022 -26.38%
Mar 31, 2022 -26.26%
Dec 31, 2021 8.91%
Sep 30, 2021 15.79%
Jun 30, 2021 461.66%
Mar 31, 2021 827.26%
Dec 31, 2020 490.78%
Sep 30, 2020 422.48%
Jun 30, 2020 11.98%
Mar 31, 2020 -13.30%
Dec 31, 2019 25.07%
Sep 30, 2019 17.81%
Jun 30, 2019 3.19%
Mar 31, 2019 -32.70%
Dec 31, 2018 -44.80%
Sep 30, 2018 -50.09%
Jun 30, 2018 -41.80%
Mar 31, 2018 -37.89%
Dec 31, 2017 -49.79%
Sep 30, 2017 -41.00%
Jun 30, 2017 -47.00%
Mar 31, 2017 -44.25%
Dec 31, 2016 -37.76%
Sep 30, 2016 -32.36%
Jun 30, 2016 -27.66%
Mar 31, 2016 178.47%
Dec 31, 2015 145.31%
Sep 30, 2015 135.03%
Jun 30, 2015 119.64%
Mar 31, 2015 -41.47%
Dec 31, 2014 -5.57%
Sep 30, 2014 -5.74%
Jun 30, 2014 -1.17%
Mar 31, 2014 447.35%
Dec 31, 2013 431.88%
Sep 30, 2013 452.80%
Jun 30, 2013 444.63%
Mar 31, 2013 -16.52%
Dec 31, 2012 -50.60%
Sep 30, 2012 -46.72%
Jun 30, 2012 -55.53%
Dec 31, 2011 -20.28%